Elevate your local knowledge
Sign up for the iNFOnews newsletter today!
VANCOUVER – Cardiome Pharma Corp. (TSX:COM) said Monday it has bought Correvio LLC, a privately held Swiss drug company. Under the deal, Cardiome has agreed to acquire Correvio in exchange for 19.9 per cent of Cardiome’s outstanding shares and US$12 million in deferred cash compensation.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Want to share your thoughts, add context, or connect with others in your community?
You must be logged in to post a comment.